Alembic Pharma Gets US FDA EIR for Oncology Plant

30 April 2025, Mumbai: Alembic Pharmaceuticals Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Oncology Formulation Facility (Injectable and Oral Solid), located at Panelav….